Rate My Professor Philip Pattemore

Philip K. Pattemore is Associate Professor of Paediatrics in the Department of Paediatrics at the University of Otago, Christchurch, a position he has held since 1992. He also serves as a paediatric specialist at Canterbury District Health Board in Christchurch since 1992 and was Honorary Senior Lecturer in the Department of Paediatrics at the University of Auckland from 1996 to 1998. Pattemore qualified with degrees BHB, MB ChB, and MD from the University of Auckland, and holds Fellowship of the Royal Australasian College of Physicians (FRACP). His academic and clinical roles include convening the 5th year Paediatric Attachment and serving as paediatric representative on the Curriculum Committee at the University of Otago, Christchurch. He coordinates Paediatric Respiratory Services at Christchurch Hospital, convenes the Respiratory Committee of the Paediatric Society of New Zealand, acts as paediatric examiner on the Examinations Committee of the Royal Australasian College of Physicians, and sits on the Editorial Advisory Board of New Ethicals magazine.

Pattemore's research specializations encompass the epidemiology and natural history of asthma and bronchial hyperresponsiveness, viral infections as triggers of asthma exacerbations, asthma management strategies, risks to children from environmental tobacco smoke exposure, and cystic fibrosis lung disease with emphasis on infection and oxidative damage. He has contributed significantly to international paediatric respiratory research, notably through participation in the International Study of Asthma and Allergies in Childhood (ISAAC), resulting in highly cited publications such as 'Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC' (1998, European Respiratory Journal) and 'Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC)' (1998, European Respiratory Journal). Recent works include 'Cough and cough hypersensitivity as treatable traits of asthma' (2023, The Lancet Respiratory Medicine), 'Sputum inflammatory, neural, and remodeling mediators in eosinophilic and noneosinophilic asthma' (2023, Annals of Allergy, Asthma & Immunology), and studies on vaping risks and knowledge among New Zealand high school students (2023, 2025, New Zealand Medical Journal). His scholarly output totals over 100 publications with more than 9,300 citations.